Literature DB >> 970990

Indomethacin serum concentrations in man. Effects of dosage, food, and antacid.

H W Emori, H Paulus, R Bluestone, G D Champion, C Pearson.   

Abstract

In the use of anti-inflammatory compounds, sustained serum levels are thought to be related to drug efficacy. This study shows that frequent clinical administration of indomethacin can result in sustained serum levels of the drug and that food and antacid may have important modifying effects on serum indomethacin concentrations. After oral ingestion by fasting subjects, indomethacin rapidly appeared in the serum, usually reaching peak concentrations in 30 to 90 minutes. Food delayed and decreased the mean peak level; antacid delayed the peak and slightly enhanced subsequent concentrations. With multiple dose schedules plateau levels were reached after 24 hours. When a total daily dose of 150 mg was given as 25 mg every 4 hours peak concentrations were the same but fluctuations were smaller and average concentrations were higher than with a dosage of 50 mg every 8 hours.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970990      PMCID: PMC1007391          DOI: 10.1136/ard.35.4.333

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  EFFECT OF ALUMINUM HYDROXIDE GEL ON BLOOD CONCENTRATIONS OF PARA-AMINOSALICYLIC ACID.

Authors:  F S LANSDOWN; I RADZIN
Journal:  Am Rev Respir Dis       Date:  1963-11

2.  Effect of concurrent administration of aspirin and indomethacin on serum concentrations.

Authors:  B Lindquist; K M Jensen; H Johansson; T Hansen
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

3.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

Review 4.  Drug interactions in clinical medicine.

Authors:  V M Rosenoer; G M Gill
Journal:  Med Clin North Am       Date:  1972-05       Impact factor: 5.456

5.  Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.

Authors:  C G Van Arman; G W Nuss; E A Risley
Journal:  J Pharmacol Exp Ther       Date:  1973-11       Impact factor: 4.030

6.  Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.

Authors:  H W Emori; G D Champion; R Bluestone; H E Paulus
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

7.  Indomethacin: plasma concentrations and protein binding in man.

Authors:  E Hvidberg; H H Lausen; J A Jansen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

8.  Drug therapy. Serum drug concentrations as therapeutic guides.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

9.  Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects.

Authors:  P Donnelly; K Lloyd; H Campbell
Journal:  Br Med J       Date:  1967-01-14

10.  [Distribution of indomethacin in blood and synovial fluid of patients with rheumatoid arthritis].

Authors:  I Caruso
Journal:  Arzneimittelforschung       Date:  1971-11
View more
  16 in total

1.  The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro.

Authors:  F Martinez; J W Coleman
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  Effect of food and various antacids on the absorption of tenoxicam.

Authors:  R O Day; S Lam; P Paull; D Wade
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  The influence of food intake on the bioavailability of timegadine, a novel non-steroidal anti-inflammatory drug.

Authors:  S George; K Dauwe; A McBurney; J Ward
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Chronopharmacokinetic study of a prolonged release form of indomethacin.

Authors:  P Guissou; G Cuisinaud; G Llorca; E Lejeune; J Sassard
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

7.  Prostaglandins and the control of airways responses to histamine in normal and asthmatic subjects.

Authors:  E H Walters
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

Review 8.  Drug interactions with antacids. Mechanisms and clinical significance.

Authors:  D C Sadowski
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

9.  Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells.

Authors:  Simona Bancos; Matthew P Bernard; David J Topham; Richard P Phipps
Journal:  Cell Immunol       Date:  2009-04-05       Impact factor: 4.868

10.  The pharmacokinetics of timegadine and two of its metabolites after multiple oral dosing, and the effects of concomitant administration of ibuprofen.

Authors:  S George; A McBurney; J W Ward
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.